BRPI1013017A2 - "17beta-alquil-17alfa-óxi-estratrienos" - Google Patents

"17beta-alquil-17alfa-óxi-estratrienos"

Info

Publication number: BRPI1013017A2
Authority: BR; Brazil
Prior art keywords: oxystratrienes; 17alpha; 17beta; alkyl
Prior art date: 2009-06-04

Application number

BRPI1013017A

Other languages

English (en)

Inventor

Dieter Lang

Georg Kettschau

Hermann Künzer

Jan Hübner

Jens Hoffmann

Karsten Denner

Michael Gerisch

Michael Sander

Nikolaus Heinrich

Philip Lienau

Rolf Bohlmann

Silke Köhr

Tim Wintermantel

Original Assignee

Bayer Pharma AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-04

Filing date

2010-05-26

Publication date

2016-03-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41460961&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1013017(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-05-26 Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG

2016-03-29 Publication of BRPI1013017A2 publication Critical patent/BRPI1013017A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

BRPI1013017A 2009-06-04 2010-05-26 "17beta-alquil-17alfa-óxi-estratrienos" BRPI1013017A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09075249A EP2258375A1 (de)	2009-06-04	2009-06-04	17B-alkyl-17alpha-oxy-estratriene
PCT/EP2010/003204 WO2010139411A2 (de)	2009-06-04	2010-05-26	17β-ALKYL-17α-OXY-ESTRATRIENE

Publications (1)

Publication Number	Publication Date
BRPI1013017A2 true BRPI1013017A2 (pt)	2016-03-29

Family

ID=41460961

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1013017A BRPI1013017A2 (pt)	2009-06-04	2010-05-26	"17beta-alquil-17alfa-óxi-estratrienos"

Country Status (27)

Country	Link
US (1)	US20120157421A1 (pt)
EP (2)	EP2258375A1 (pt)
JP (1)	JP2012528808A (pt)
KR (1)	KR20120042827A (pt)
CN (1)	CN102802634A (pt)
AR (1)	AR076980A1 (pt)
AU (1)	AU2010256035A1 (pt)
BR (1)	BRPI1013017A2 (pt)
CA (1)	CA2764249A1 (pt)
CL (1)	CL2011003050A1 (pt)
CO (1)	CO6470855A2 (pt)
CR (1)	CR20110647A (pt)
CU (1)	CU20110224A7 (pt)
DO (1)	DOP2011000374A (pt)
EA (1)	EA201101703A1 (pt)
EC (1)	ECSP11011501A (pt)
IL (1)	IL216524A0 (pt)
MA (1)	MA33329B1 (pt)
MX (1)	MX2011012878A (pt)
NZ (1)	NZ596824A (pt)
PE (1)	PE20120318A1 (pt)
SG (1)	SG176630A1 (pt)
TN (1)	TN2011000617A1 (pt)
TW (1)	TW201103547A (pt)
UY (1)	UY32688A (pt)
WO (1)	WO2010139411A2 (pt)
ZA (1)	ZA201200036B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN116041412A (zh) *	2023-01-13	2023-05-02	香港中文大学（深圳）	氟维司群衍生物及其制备方法、应用和治疗乳腺癌的药物
CN116535454A (zh) *	2023-04-28	2023-08-04	香港中文大学（深圳）	氟维司群类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8327256D0 (en)	1983-10-12	1983-11-16	Ici Plc	Steroid derivatives
EP0310542B1 (de)	1987-10-01	1994-06-08	Schering Aktiengesellschaft	Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
GB8813353D0 (en)	1988-06-06	1988-07-13	Ici Plc	Therapeutic product
DE19510862A1 (de)	1995-03-16	1996-09-19	Schering Ag	Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
DE19622457A1 (de)	1996-05-24	1997-11-27	Schering Ag	7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19635525A1 (de)	1996-08-20	1998-02-26	Schering Ag	7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
AR015500A1 (es)	1997-12-23	2001-05-02	Schering Ag	11 BETA-HALoGENO-ESTRATRIENOS SUSTITUIDOS EN 7 ALFA, PROCEDIMIENTO PARA ELABORAR PREPARADOS FARMACEUTICOS QUE CONTIENEN TALES 11 BETA-HALOGENO-ESTRATRIENOSSUSTITUIDOS EN 7 ALFA, ASI COMO SU UTILIZACION EN LA ELABORACION DE MEDICAMENTOS.
DE10019171A1 (de)	2000-04-07	2001-10-18	Schering Ag	Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10159217A1 (de)	2001-11-27	2003-06-05	Schering Ag	17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate

2009
- 2009-06-04 EP EP09075249A patent/EP2258375A1/de not_active Withdrawn
2010
- 2010-05-26 PE PE2011002048A patent/PE20120318A1/es not_active Application Discontinuation
- 2010-05-26 EA EA201101703A patent/EA201101703A1/ru unknown
- 2010-05-26 BR BRPI1013017A patent/BRPI1013017A2/pt not_active Application Discontinuation
- 2010-05-26 NZ NZ596824A patent/NZ596824A/xx not_active IP Right Cessation
- 2010-05-26 AU AU2010256035A patent/AU2010256035A1/en not_active Abandoned
- 2010-05-26 CN CN2010800342808A patent/CN102802634A/zh active Pending
- 2010-05-26 US US13/376,194 patent/US20120157421A1/en not_active Abandoned
- 2010-05-26 JP JP2012513491A patent/JP2012528808A/ja not_active Withdrawn
- 2010-05-26 CA CA2764249A patent/CA2764249A1/en not_active Abandoned
- 2010-05-26 SG SG2011089034A patent/SG176630A1/en unknown
- 2010-05-26 KR KR1020127000101A patent/KR20120042827A/ko not_active Withdrawn
- 2010-05-26 MA MA34401A patent/MA33329B1/fr unknown
- 2010-05-26 WO PCT/EP2010/003204 patent/WO2010139411A2/de not_active Ceased
- 2010-05-26 MX MX2011012878A patent/MX2011012878A/es unknown
- 2010-05-26 EP EP10722316A patent/EP2437746A2/de not_active Withdrawn
- 2010-06-03 UY UY0001032688A patent/UY32688A/es not_active Application Discontinuation
- 2010-06-04 TW TW099118274A patent/TW201103547A/zh unknown
- 2010-06-04 AR ARP100101978A patent/AR076980A1/es unknown
2011
- 2011-11-22 IL IL216524A patent/IL216524A0/en unknown
- 2011-12-02 TN TNP2011000617A patent/TN2011000617A1/en unknown
- 2011-12-02 CL CL2011003050A patent/CL2011003050A1/es unknown
- 2011-12-02 EC EC2011011501A patent/ECSP11011501A/es unknown
- 2011-12-02 DO DO2011000374A patent/DOP2011000374A/es unknown
- 2011-12-02 CU CU20110224A patent/CU20110224A7/es unknown
- 2011-12-02 CO CO11166108A patent/CO6470855A2/es not_active Application Discontinuation
- 2011-12-02 CR CR20110647A patent/CR20110647A/es unknown
2012
- 2012-01-03 ZA ZA2012/00036A patent/ZA201200036B/en unknown

Also Published As

Publication number	Publication date
EA201101703A1 (ru)	2012-06-29
CU20110224A7 (es)	2012-04-15
US20120157421A1 (en)	2012-06-21
KR20120042827A (ko)	2012-05-03
MX2011012878A (es)	2012-01-12
SG176630A1 (en)	2012-01-30
CO6470855A2 (es)	2012-06-29
CR20110647A (es)	2012-02-16
IL216524A0 (en)	2012-02-29
MA33329B1 (fr)	2012-06-01
EP2437746A2 (de)	2012-04-11
TW201103547A (en)	2011-02-01
JP2012528808A (ja)	2012-11-15
ECSP11011501A (es)	2012-01-31
NZ596824A (en)	2013-07-26
ZA201200036B (en)	2013-06-26
AU2010256035A1 (en)	2011-12-22
WO2010139411A2 (de)	2010-12-09
CL2011003050A1 (es)	2012-06-15
EP2258375A1 (de)	2010-12-08
UY32688A (es)	2010-12-31
CA2764249A1 (en)	2010-12-09
TN2011000617A1 (en)	2013-05-24
CN102802634A (zh)	2012-11-28
AR076980A1 (es)	2011-07-20
PE20120318A1 (es)	2012-03-24
DOP2011000374A (es)	2012-01-15
WO2010139411A3 (de)	2011-03-10

Legal Events

Date	Code	Title	Description
2016-05-31	B11A	Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
2016-08-16	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]

Publication	Publication Date	Title
BR112012012872A2 (pt)	2017-10-10	"pirrolindinas de espiroindolinona"
BRPI1010909A2 (pt)	2015-09-08	"inseticida arilpirrolinas"
BRPI1011813A2 (pt)	2016-03-29	"inalador"
SMT201500053B (it)	2015-05-05	2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BR112012007164A2 (pt)	2016-03-29	"veículo"
FR2941508B1 (fr)	2017-04-21	Agencement d'entrainement
BR112012004593A2 (pt)	2017-05-23	"método"
BRPI1015540A2 (pt)	2019-09-24	''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
BRPI1014856A2 (pt)	2016-05-03	"elementos de tração"
BR112012004444A2 (pt)	2016-03-22	"laringoscópio"
BRPI1013015A2 (pt)	2016-03-29	"osteosíntese com nanoprata"
BRPI0910229A2 (pt)	2015-09-01	Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BR112012010595A2 (pt)	2016-03-22	"dispensdor"
BRPI0914533A2 (pt)	2015-12-15	"métodos"
BRPI1013030A2 (pt)	2016-04-05	"aquecedores"
UY33125A (es)	2011-07-29	Diaza-espiro-[5,5]-undecanos
FR2950411B1 (fr)	2017-07-21	Agencement d'entrainement
EP2467559A4 (en)	2015-12-23	IMPROVED NON-PLANN INTERFACE CONSTRUCTION
BR112012003701A2 (pt)	2019-09-24	"novos antagonistas de quinolina-hepcidina"
BRPI0814519A2 (pt)	2014-09-30	Organopolissiloxano
BRPI1013001A2 (pt)	2015-09-15	"bioprocessamento"
FR2944062B1 (fr)	2011-06-03	Injecteur d'ergols
FR2952847B3 (fr)	2011-12-09	>
BRPI1010178A2 (pt)	2018-02-20	"válvula"
BRPI1010778A2 (pt)	2016-03-22	"escada dupla"